(Sharecast News) - AstraZeneca has received the green light from European regulators for its Saphnelo treatment for lupus, the pharma giant announced on Monday.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended Saphnelo for approval as a self-administered, once-weekly pre-filled pen for...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE